Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
08 2020
Historique:
received: 08 08 2017
accepted: 23 04 2018
revised: 15 04 2018
pubmed: 14 6 2018
medline: 23 3 2021
entrez: 14 6 2018
Statut: ppublish

Résumé

The 22q11.2 deletion (22q11DS) is a common chromosomal microdeletion and a potent risk factor for psychotic illness. Prior studies reported widespread cortical changes in 22q11DS, but were generally underpowered to characterize neuroanatomic abnormalities associated with psychosis in 22q11DS, and/or neuroanatomic effects of variability in deletion size. To address these issues, we developed the ENIGMA (Enhancing Neuro Imaging Genetics Through Meta-Analysis) 22q11.2 Working Group, representing the largest analysis of brain structural alterations in 22q11DS to date. The imaging data were collected from 10 centers worldwide, including 474 subjects with 22q11DS (age = 18.2 ± 8.6; 46.9% female) and 315 typically developing, matched controls (age = 18.0 ± 9.2; 45.9% female). Compared to controls, 22q11DS individuals showed thicker cortical gray matter overall (left/right hemispheres: Cohen's d = 0.61/0.65), but focal thickness reduction in temporal and cingulate cortex. Cortical surface area (SA), however, showed pervasive reductions in 22q11DS (left/right hemispheres: d = -1.01/-1.02). 22q11DS cases vs. controls were classified with 93.8% accuracy based on these neuroanatomic patterns. Comparison of 22q11DS-psychosis to idiopathic schizophrenia (ENIGMA-Schizophrenia Working Group) revealed significant convergence of affected brain regions, particularly in fronto-temporal cortex. Finally, cortical SA was significantly greater in 22q11DS cases with smaller 1.5 Mb deletions, relative to those with typical 3 Mb deletions. We found a robust neuroanatomic signature of 22q11DS, and the first evidence that deletion size impacts brain structure. Psychotic illness in this highly penetrant deletion was associated with similar neuroanatomic abnormalities to idiopathic schizophrenia. These consistent cross-site findings highlight the homogeneity of this single genetic etiology, and support the suitability of 22q11DS as a biological model of schizophrenia.

Identifiants

pubmed: 29895892
doi: 10.1038/s41380-018-0078-5
pii: 10.1038/s41380-018-0078-5
pmc: PMC6292748
mid: NIHMS962497
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1822-1834

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH087626
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH073526
Pays : United States
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100202/Z/12/Z
Pays : United Kingdom
Organisme : CIHR
ID : MOP 74631
Pays : Canada
Organisme : NIMH NIH HHS
ID : U01 MH101723
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH101719
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD087101
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085953
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD105354
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : CIHR
ID : MOP 79518
Pays : Canada
Organisme : CIHR
ID : MOP 89066
Pays : Canada
Organisme : CIHR
ID : MOP 111238
Pays : Canada
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH100900
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD086984
Pays : United States
Organisme : CIHR
ID : MOP 97800
Pays : Canada
Organisme : NIMH NIH HHS
ID : U01 MH101724
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Organisme : Wellcome Trust
ID : 102003/Z/13/Z
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : U01 MH087636
Pays : United States
Organisme : NIMH NIH HHS
ID : RC2 MH089983
Pays : United States

Références

Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009;25:528–35.
pubmed: 19883952 pmcid: 3351381 doi: 10.1016/j.tig.2009.10.004
McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, et al. 22q11.2 deletion syndrome. Nat Rev Dis Prim. 2015;1:15071.
pubmed: 27189754 doi: 10.1038/nrdp.2015.71
CNV, Schizophrenia Working Groups of the Psychiatric Genomics Consortium, Psychosis Endophenotypes International Consortium. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49:27–35.
Bassett AS,Chow EW, Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep. 2008;10:148–57.
pubmed: 18474208 pmcid: 3129332 doi: 10.1007/s11920-008-0026-1
Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009;48:1060–8.
pubmed: 19797984 doi: 10.1097/CHI.0b013e3181b76683
Schneider M, Debbane M, Bassett AS, Chow EW, Fung WL, van den Bree M, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171:627–39.
pubmed: 24577245 pmcid: 4285461 doi: 10.1176/appi.ajp.2013.13070864
Schmock H, Vangkilde A, Larsen KM, Fischer E, Birknow MR, Jepsen JR, et al. The Danish 22q11 research initiative. BMC Psychiatry. 2015;15:220.
pubmed: 26384214 pmcid: 4574168 doi: 10.1186/s12888-015-0594-7
Bearden CE, van Erp TG, Dutton RA, Tran H, Zimmermann L, Sun D, et al. Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex. 2007;17:1889–98.
pubmed: 17056649 doi: 10.1093/cercor/bhl097
Eliez S, Schmitt JE, White CD, Reiss AL. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry. 2000;157:409–15.
pubmed: 10698817 doi: 10.1176/appi.ajp.157.3.409
Kates WR, Burnette CP, Jabs EW, Rutberg J, Murphy AM, Grados M, et al. Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry. 2001;49:677–84.
pubmed: 11313035 doi: 10.1016/S0006-3223(00)01002-7
Campbell LE, Daly E, Toal F, Stevens A, Azuma R, Catani M, et al. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain. 2006;129:1218–28.
pubmed: 16569671 doi: 10.1093/brain/awl066
Tan GM, Arnone D, McIntosh AM, Ebmeier KP. Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome). Schizophr Res. 2009;115:173–81.
pubmed: 19819113 doi: 10.1016/j.schres.2009.09.010
Jalbrzikowski M, Jonas R, Senturk D, Patel A, Chow C, Green MF, et al. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms. Neuroimage Clin. 2013;3:405–15.
pubmed: 24273724 pmcid: 3814944 doi: 10.1016/j.nicl.2013.09.013
Schmitt JE, Vandekar S, Yi J, Calkins ME, Ruparel K, Roalf DR, et al. Aberrant cortical morphometry in the 22q11.2 deletion syndrome. Biol Psychiatry. 2015;78:135–43.
pubmed: 25555483 doi: 10.1016/j.biopsych.2014.10.025
Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage. 2010;53:1135–46.
pubmed: 20006715 doi: 10.1016/j.neuroimage.2009.12.028
Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009;19:2728–35.
pubmed: 19299253 pmcid: 2758684 doi: 10.1093/cercor/bhp026
Bearden CE, van Erp TG, Dutton RA, Lee AD, Simon TJ, Cannon TD, et al. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions. Cereb Cortex. 2009;19:115–26.
pubmed: 18483006 doi: 10.1093/cercor/bhn064
Scariati E, Padula MC, Schaer M, Eliez S. Long-range dysconnectivity in frontal and midline structures is associated to psychosis in 22q11.2 deletion syndrome. J Neural Transm (Vienna). 2016;123:823–39.
doi: 10.1007/s00702-016-1548-z
Chow E, Ho A, Wei C, Voormolen EHJ, Crawley AP, Bassett A. Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus. Am J Psychiatry. 2011. https://doi.org/10.1176/appi.ajp.2010.10081230 .
Jenne DE, Tinschert S, Reimann H, Lasinger W, Thiel G, Hameister H, et al. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am J Hum Genet. 2001;69:516–27.
pubmed: 11468690 pmcid: 1235482 doi: 10.1086/323043
Arango C, Kahn R. Progressive brain changes in schizophrenia. Schizophr Bull. 2008;34:310–1.
pubmed: 18212323 pmcid: 2632394 doi: 10.1093/schbul/sbm166
Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull. 2008;34:354–66.
pubmed: 18283048 pmcid: 2632411 doi: 10.1093/schbul/sbm168
Shepherd AM, Matheson SL, Laurens KR, Carr VJ, Green MJ. Systematic meta-analysis of insula volume in schizophrenia. Biol Psychiatry. 2012;72:775–84.
pubmed: 22621997 doi: 10.1016/j.biopsych.2012.04.020
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:585.
pubmed: 26283641 doi: 10.1038/mp.2015.118
Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008;165:1015–23.
pubmed: 18381902 pmcid: 2873788 doi: 10.1176/appi.ajp.2008.07101562
Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry. 2008;64:774–81.
pubmed: 18486104 pmcid: 5441233 doi: 10.1016/j.biopsych.2008.03.031
Bakker G, Caan MW, Vingerhoets WA, da Silva-Alves F, de Koning M, Boot E, et al. Cortical morphology differences in subjects at increased vulnerability for developing a psychotic disorder: a comparison between subjects with ultra-high risk and 22q11.2 deletion syndrome. PLoS One. 2016;11:e0159928.
pubmed: 27828960 pmcid: 5102447 doi: 10.1371/journal.pone.0159928
van Amelsvoort T, Daly E, Henry J, Robertson D, Ng V, Owen M, et al. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry. 2004;61:1085–96.
pubmed: 15520356 doi: 10.1001/archpsyc.61.11.1085
Kates WR, Antshel KM, Faraone SV, Fremont WP, Higgins AM, Shprintzen RJ, et al. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry. 2011;69:945–52.
pubmed: 21195387 doi: 10.1016/j.biopsych.2010.10.027
Dufour F, Schaer M, Debbane M, Farhoumand R, Glaser B, Eliez S. Cingulate gyral reductions are related to low executive functioning and psychotic symptoms in 22q 11.2 deletion syndrome. Neuropsychologia. 2008;46:2986–92.
pubmed: 18616958 doi: 10.1016/j.neuropsychologia.2008.06.012
Bearden CE, Thompson PM. Emerging global initiatives in neurogenetics: The Enhancing Neuroimaging Genetics through Meta-analysis (ENIGMA) Consortium. Neuron. 2017;94:232–6.
pubmed: 28426957 pmcid: 5918136 doi: 10.1016/j.neuron.2017.03.033
Thompson PM, Andreassen OA, Arias-Vasquez A, Bearden CE, Boedhoe PS, Brouwer RM, et al. ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide. Neuroimage. 2017;145:389–408.
pubmed: 26658930 doi: 10.1016/j.neuroimage.2015.11.057
Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 2014;8:153–82.
pubmed: 24399358 pmcid: 4008818 doi: 10.1007/s11682-013-9269-5
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.
pubmed: 11832223 doi: 10.1016/S0896-6273(02)00569-X
Schmaal L, Hibar DP, Samann PG, Hall GB, Baune BT, Jahanshad N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017;22:900–9.
pubmed: 27137745 doi: 10.1038/mp.2016.60
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry. 2017;23:932–42.
Joyner AH, J CR, Bloss CS, Bakken TE, Rimol LM, Melle I, et al. A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations. Proc Natl Acad Sci USA. 2009;106:15483–8.
pubmed: 19717458 doi: 10.1073/pnas.0901866106 pmcid: 2741277
Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–80.
pubmed: 16530430 doi: 10.1016/j.neuroimage.2006.01.021
Cohen J. A power primer. Psychol Bull. 1992;112:155–9.
pubmed: 19565683 doi: 10.1037/0033-2909.112.1.155
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. 2014. http://www.R-project.org/
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1–22.
pubmed: 20808728 pmcid: 2929880 doi: 10.18637/jss.v033.i01
Kuhn M. Caret: classification and regression training. 2016. https://github.com/topepo/caret
Gur RE, Bassett AS, McDonald-McGinn DM, Bearden CE, Chow E, Emanuel BS, et al. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium. Mol Psychiatry. 2017;22:1664–72.
pubmed: 28761081 pmcid: 5935262 doi: 10.1038/mp.2017.161
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Cortical abnormalities in schizophrenia: An ENIGMA Schizophrenia Working Group Mega-Analysis. Biol Psychiatry. 2018, in press.
Sorensen KM, Agergaard P, Olesen C, Andersen PS, Larsen LA, Ostergaard JR, et al. Detecting 22q11.2 deletions by use of multiplex ligation-dependent probe amplification on DNA from neonatal dried blood spot samples. J Mol Diagn. 2010;12:147–51.
pubmed: 20075206 pmcid: 2871720 doi: 10.2353/jmoldx.2010.090099
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Cortical abnormalities in schizophrenia: An ENIGMA Schizophrenia Working Group Meta-Analysis. Hum Brain Mapp. Vol. 23. Vancouver, BC: 2017. S:1356.
Ellegood J, Markx S, Lerch JP, Steadman PE, Genc C, Provenzano F, et al. A highly specific pattern of volumetric brain changes due to 22q11.2 deletions in both mice and humans. Mol Psychiatry. 2014;19:6.
pubmed: 24362540 doi: 10.1038/mp.2013.179
Ellegood J, Markx S, Lerch JP, Steadman PE, Genc C, Provenzano F, et al. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Mol Psychiatry. 2014;19:99–107.
pubmed: 23999526 doi: 10.1038/mp.2013.112
Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003;160:1580–6.
pubmed: 12944331 pmcid: 3276594 doi: 10.1176/appi.ajp.160.9.1580
Monks S, Niarchou M, Davies AR, Walters JT, Williams N, Owen MJ, et al. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophr Res. 2014;153:231–6.
pubmed: 24534796 doi: 10.1016/j.schres.2014.01.020
Michaelovsky E, Frisch A, Carmel M, Patya M, Zarchi O, Green T, et al. Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med Genet. 2012;13:122.
pubmed: 23245648 pmcid: 3548696 doi: 10.1186/1471-2350-13-122
Chow EW, Zipursky RB, Mikulis DJ, Bassett AS. Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry. 2002;51:208–15.
pubmed: 11839363 pmcid: 3295830 doi: 10.1016/S0006-3223(01)01246-X
Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R, et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet. 1997;61:620–9.
pubmed: 9326327 pmcid: 1715959 doi: 10.1086/515508
Schaer M, Debbane M, Bach Cuadra M, Ottet MC, Glaser B, Thiran JP, et al. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr Res. 2009;115:182–90.
pubmed: 19836927 doi: 10.1016/j.schres.2009.09.016
Storsve AB, Fjell AM, Tamnes CK, Westlye LT, Overbye K, Aasland HW, et al. Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: regions of accelerating and decelerating change. J Neurosci. 2014;34:8488–98.
pubmed: 24948804 pmcid: 6608217 doi: 10.1523/JNEUROSCI.0391-14.2014
Wierenga LM, Langen M, Oranje B, Durston S. Unique developmental trajectories of cortical thickness and surface area. Neuroimage. 2014;87:120–6.
pubmed: 24246495 doi: 10.1016/j.neuroimage.2013.11.010
Rakic P. Specification of cerebral cortical areas. Science. 1988;241:170–6.
pubmed: 3291116 doi: 10.1126/science.3291116
Rakic P. Young neurons for old brains? Nat Neurosci. 1998;1:645–7.
pubmed: 10196576 doi: 10.1038/3643
Rakic P, Lombroso PJ. Development of the cerebral cortex: I. forming the cortical structure. J Am Acad Child Adolesc Psychiatry. 1998;37:116–7.
pubmed: 9444908 doi: 10.1097/00004583-199801000-00026
Raznahan A, Shaw P, Lalonde F, Stockman M, Wallace GL, Greenstein D, et al. How does your cortex grow? J Neurosci. 2011;31:7174–7.
pubmed: 21562281 pmcid: 3157294 doi: 10.1523/JNEUROSCI.0054-11.2011
Guna A, Butcher NJ, Bassett AS. Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms. J Neurodev Disord. 2015;7:18.
pubmed: 26137170 pmcid: 4487986 doi: 10.1186/s11689-015-9113-x
Meechan DW, Maynard TM, Tucker ES, Fernandez A, Karpinski BA, Rothblat LA, et al. Modeling a model: mouse genetics, 22q11.2 deletion syndrome, and disorders of cortical circuit development. Prog Neurobiol. 2015;130:1–28.
pubmed: 25866365 pmcid: 5019355 doi: 10.1016/j.pneurobio.2015.03.004
Paronett EM, Meechan DW, Karpinski BA, LaMantia AS, Maynard TM. Ranbp1, deleted in DiGeorge/22q11.2 deletion syndrome, is a microcephaly gene that selectively disrupts layer 2/3 cortical projection neuron generation. Cereb Cortex. 2015;25:3977–93.
pubmed: 25452572 doi: 10.1093/cercor/bhu285
Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 2010;464:763–7.
pubmed: 20360742 pmcid: 2864584 doi: 10.1038/nature08855
Gur R, Bassett A, McDonald-McGinn D, Bearden C, Chow E, Emanuel B, et al. A neurogenetic model for the study of schizophrenia spectrum disorders: The International 22q11.2 Deletion Syndrome Brain Behavior Consortium. Mol Psychiatry. 2018, in press.
brainGraph: Graph Theory Analysis of Brain MRI Data. 2018, https://github.com/cwatson/brainGraph . Accessed 23 Feb. 2018.

Auteurs

Daqiang Sun (D)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Mental Health, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.

Christopher R K Ching (CRK)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
Interdepartmental Neuroscience Program, University of California, Los Angeles, Los Angeles, CA, USA.

Amy Lin (A)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Interdepartmental Neuroscience Program, University of California, Los Angeles, Los Angeles, CA, USA.

Jennifer K Forsyth (JK)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA.

Leila Kushan (L)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.

Ariana Vajdi (A)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.

Maria Jalbrzikowski (M)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

Laura Hansen (L)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.

Julio E Villalon-Reina (JE)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Xiaoping Qu (X)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Rachel K Jonas (RK)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Interdepartmental Neuroscience Program, University of California, Los Angeles, Los Angeles, CA, USA.

Therese van Amelsvoort (T)

Department of Psychiatry & Neuropsychology, Maastricht University, Maastricht, Netherlands.

Geor Bakker (G)

Department of Psychiatry & Neuropsychology, Maastricht University, Maastricht, Netherlands.

Wendy R Kates (WR)

Department of Psychiatry and Behavioral Sciences, State University of New York, Upstate Medical University, Syracuse, NY, USA.

Kevin M Antshel (KM)

Department of Psychology, Syracuse University, Syracuse, NY, USA.

Wanda Fremont (W)

Department of Psychiatry and Behavioral Sciences, State University of New York, Upstate Medical University, Syracuse, NY, USA.

Linda E Campbell (LE)

PRC GrowUpWell, University of Newcastle, Newcastle, Australia.
School of Psychology, University of Newcastle, Newcastle, Australia.

Kathryn L McCabe (KL)

School of Psychology, University of Newcastle, Newcastle, Australia.
UC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, Davis, CA, USA.

Eileen Daly (E)

Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.

Maria Gudbrandsen (M)

Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.

Clodagh M Murphy (CM)

Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
Behavioural Genetics Clinic, Adult Autism Service, Behavioural and Developmental Psychiatry Clinical Academic Group, South London and Maudsley Foundation NHS Trust, London, UK.

Declan Murphy (D)

Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
Behavioural Genetics Clinic, Adult Autism Service, Behavioural and Developmental Psychiatry Clinical Academic Group, South London and Maudsley Foundation NHS Trust, London, UK.

Michael Craig (M)

Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
National Autism Unit, Bethlem Royal Hospital, Behavioural and Developmental Psychiatry Clinical Academic Group, South London and Maudsley Foundation NHS Trust, London, UK.

Jacob Vorstman (J)

Hospital for Sick Children, Toronto, ON, Canada.
Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Ania Fiksinski (A)

Hospital for Sick Children, Toronto, ON, Canada.
Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
The Dalglish Family 22q Clinic, Department of Psychiatry, and Toronto General Research Institute, University Health Network, Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Sanne Koops (S)

Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

Kosha Ruparel (K)

Department of Psychiatry, University of Pennsylvania, and the Lifespan Brain Institute, Penn Medicine and the Children's Hospital of Philadelphia, Philadelphia, PA, USA.

David R Roalf (DR)

Department of Psychiatry, University of Pennsylvania, and the Lifespan Brain Institute, Penn Medicine and the Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Raquel E Gur (RE)

Department of Radiology, Division of Neuroradiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Psychiatry, University of Pennsylvania, and the Lifespan Brain Institute, Penn Medicine and the Children's Hospital of Philadelphia, Philadelphia, PA, USA.

J Eric Schmitt (JE)

Department of Radiology, Division of Neuroradiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Psychiatry, University of Pennsylvania, and the Lifespan Brain Institute, Penn Medicine and the Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Tony J Simon (TJ)

UC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, Davis, CA, USA.

Naomi J Goodrich-Hunsaker (NJ)

UC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, Davis, CA, USA.
Department of Psychology, Brigham Young University, Provo, UT, USA.

Courtney A Durdle (CA)

UC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, Davis, CA, USA.

Anne S Bassett (AS)

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
The Dalglish Family 22q Clinic, Department of Psychiatry, and Toronto General Research Institute, University Health Network, Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Eva W C Chow (EWC)

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Nancy J Butcher (NJ)

Hospital for Sick Children, Toronto, ON, Canada.
Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Fidel Vila-Rodriguez (F)

Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.

Joanne Doherty (J)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Adam Cunningham (A)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Marianne B M van den Bree (MBM)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

David E J Linden (DEJ)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Hayley Moss (H)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Michael J Owen (MJ)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Kieran C Murphy (KC)

Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Donna M McDonald-McGinn (DM)

Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Clinical Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Beverly Emanuel (B)

Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Clinical Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Theo G M van Erp (TGM)

Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, USA.

Jessica A Turner (JA)

Imaging Genetics and Neuroinformatics Lab, Department of Psychology, Georgia State University, Atlanta, GA, USA.
Mind Research Network, Albuquerque, NM, USA.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
Departments of Neurology, Psychiatry, Radiology, Engineering, Pediatrics and Ophthalmology, University of Southern California, California, CA, USA.

Carrie E Bearden (CE)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA. CBearden@mednet.ucla.edu.
Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA. CBearden@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH